Your browser doesn't support javascript.
loading
The extent of surgery for low-risk 1-4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35.
Anda Apiñániz, Emma; Zafon, Carles; Ruiz Rey, Irati; Perdomo, Carolina; Pineda, Javier; Alcalde, Juan; García Goñi, Marta; Galofré, Juan C.
Afiliação
  • Anda Apiñániz E; Department of Endocrinology and Nutrition, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Zafon C; IdiSNA (Instituto de investigación en la Salud de Navarra), Pamplona, Spain.
  • Ruiz Rey I; SEEN (Sociedad Española de Endocrinología y Nutrición) Thyroid Task-Force, Pamplona, Spain.
  • Perdomo C; SEEN (Sociedad Española de Endocrinología y Nutrición) Thyroid Task-Force, Pamplona, Spain.
  • Pineda J; Department of Endocrinology and Nutrition, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Alcalde J; Department of Endocrinology and Nutrition, Clínica Universidad de Navarra. University of Navarra, Pamplona, Spain.
  • García Goñi M; Department of Endocrinology and Nutrition, Clínica Universidad de Navarra. University of Navarra, Pamplona, Spain.
  • Galofré JC; Department of Endocrinology and Nutrition, Complejo Hospitalario de Navarra, Pamplona, Spain.
Endocrine ; 70(3): 538-543, 2020 12.
Article em En | MEDLINE | ID: mdl-32507966
ABSTRACT

PURPOSE:

The adequate extent of surgery for 1-4 cm low-risk papillary thyroid carcinoma (PTC) is unclear. Our objective was to analyze the applicability of the 2015 ATA Guidelines recommendation 35B (R35) for the management low-risk PTC.

METHODS:

This multicentre study included patients with low-risk PTC who had undergone total thyroidectomy (TT). Retrospectively we selected those who met the R35 criteria for the performance of a thyroid lobectomy (TL). The aim was to identify the proportion of low-risk PTC patients treated using TT who would have required reintervention had they had a TL in accordance with R35.

RESULTS:

We identified 497 patients (400 female; 80.5%). Median tumor size (mm) 21.2 (11-40). A tumor size ≥2 cm was found in 252 (50.7%). Most of them, 320 (64.4%), were in Stage I (AJCC 7th Edition). Following R35, 286 (57.5%) would have needed TT. Thus, they would have required a second surgery had they undergone TL. The indications for reintervention would have included lymph node involvement (35%), extrathyroidal extension (22.9%), aggressive subtype (8%), or vascular invasion (22.5%). No presurgical clinical data predict TT.

CONCLUSIONS:

The appropriate management of low-risk PTC is unclear. Adherence to ATA R35 could lead to a huge increase in reinterventions when a TL is performed, though the need for them would be questionable. In our sample, more than half of patients (57.5%) who may undergo a TL for a seemingly low-risk PTC would have required a second operation to satisfy international guidelines, until better preoperative diagnostic tools become available.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Craniossinostoses Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Craniossinostoses Idioma: En Ano de publicação: 2020 Tipo de documento: Article